Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
China
· Delayed Price · Currency is CNY 13.92
-0.04 (-0.29%)
May 13, 2025, 2:45 PM CST
SHE:000739 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 1,036 | 1,031 | 1,055 | 989.17 | 955.55 | 816.73 | Upgrade
|
| Depreciation & Amortization | 577.85 | 577.85 | 553.06 | 389.43 | 358.64 | 344.06 | Upgrade
|
| Other Amortization | 6.42 | 6.42 | 5.93 | 5.18 | 3.92 | 4.53 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.28 | -0.28 | -1.33 | -1.37 | -0.28 | -8.52 | Upgrade
|
| Asset Writedown & Restructuring Costs | 8.4 | 8.4 | 7.79 | 4.67 | 55.84 | 43.74 | Upgrade
|
| Loss (Gain) From Sale of Investments | -6.21 | -6.21 | 18.08 | 82.61 | -66.73 | -109.46 | Upgrade
|
| Provision & Write-off of Bad Debts | 9.46 | 9.46 | 1.92 | 12.71 | - | - | Upgrade
|
| Other Operating Activities | -245.76 | 54.19 | 164.86 | 12.27 | -13.57 | 42.58 | Upgrade
|
| Change in Accounts Receivable | -251.45 | -251.45 | -571.63 | -1,108 | -851.44 | -176.76 | Upgrade
|
| Change in Inventory | 152.99 | 152.99 | -373.35 | -603.07 | -190.08 | -116.91 | Upgrade
|
| Change in Accounts Payable | -375.3 | -375.3 | 130.17 | 1,649 | 373.38 | 201.09 | Upgrade
|
| Change in Other Net Operating Assets | 0.56 | 0.56 | 36.87 | -2.74 | 0.5 | - | Upgrade
|
| Operating Cash Flow | 913.63 | 1,209 | 1,031 | 1,326 | 611.75 | 1,060 | Upgrade
|
| Operating Cash Flow Growth | -16.07% | 17.20% | -22.23% | 116.77% | -42.26% | -22.10% | Upgrade
|
| Capital Expenditures | -391.07 | -460.75 | -630.47 | -509.11 | -701.92 | -317.12 | Upgrade
|
| Sale of Property, Plant & Equipment | 9.33 | 8.51 | 8.96 | 4.87 | 3.88 | 16.68 | Upgrade
|
| Divestitures | 30.05 | 7.6 | 30.4 | - | - | - | Upgrade
|
| Investment in Securities | 47.47 | 54.36 | -77.9 | -5.78 | 92.56 | 382.63 | Upgrade
|
| Other Investing Activities | 2.98 | -7.74 | -7.79 | -81.29 | 90.1 | 24.17 | Upgrade
|
| Investing Cash Flow | -301.24 | -398.01 | -676.8 | -591.3 | -515.39 | 106.37 | Upgrade
|
| Long-Term Debt Issued | - | 1,388 | 1,061 | 1,085 | 805.16 | 484.1 | Upgrade
|
| Total Debt Issued | 1,425 | 1,388 | 1,061 | 1,085 | 805.16 | 484.1 | Upgrade
|
| Long-Term Debt Repaid | - | -1,416 | -980.02 | -725.88 | -707.57 | -204 | Upgrade
|
| Total Debt Repaid | -1,526 | -1,416 | -980.02 | -725.88 | -707.57 | -204 | Upgrade
|
| Net Debt Issued (Repaid) | -101.13 | -27.93 | 81.16 | 359.57 | 97.59 | 280.1 | Upgrade
|
| Repurchase of Common Stock | -153.09 | -153.09 | - | -200.2 | - | - | Upgrade
|
| Common Dividends Paid | -396.68 | -401.63 | -383.02 | -362.8 | -301.92 | -201.35 | Upgrade
|
| Other Financing Activities | -0.16 | 0.51 | 0.38 | 7.35 | - | - | Upgrade
|
| Financing Cash Flow | -651.07 | -582.15 | -301.48 | -196.09 | -204.32 | 78.75 | Upgrade
|
| Foreign Exchange Rate Adjustments | 34.53 | 38.37 | 27.49 | 44.04 | -17.32 | -38.28 | Upgrade
|
| Net Cash Flow | -4.14 | 266.96 | 80.57 | 582.76 | -125.29 | 1,206 | Upgrade
|
| Free Cash Flow | 522.56 | 748.01 | 400.9 | 817 | -90.18 | 742.41 | Upgrade
|
| Free Cash Flow Growth | 15.10% | 86.58% | -50.93% | - | - | -44.10% | Upgrade
|
| Free Cash Flow Margin | 4.52% | 6.22% | 3.49% | 7.75% | -1.01% | 9.42% | Upgrade
|
| Free Cash Flow Per Share | 0.45 | 0.64 | 0.34 | 0.70 | -0.08 | 0.63 | Upgrade
|
| Cash Income Tax Paid | 13.78 | 27.07 | -2.88 | -41.97 | 149.94 | -93.46 | Upgrade
|
| Levered Free Cash Flow | 310.45 | 504.46 | -28.58 | 1,366 | 554.62 | 442.19 | Upgrade
|
| Unlevered Free Cash Flow | 328.24 | 524.58 | -1.23 | 1,403 | 576.94 | 452.2 | Upgrade
|
| Change in Net Working Capital | 457.76 | 231.29 | 603.38 | -950.6 | -316.69 | 94.02 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.